Skip to content
Home/Companies/Biotech/IMU Biosciences
IB

IMU Biosciences

Biotech·UK·Active·2yr hold

IMU Biosciences is a biotech company, headquartered in UK.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns IMU Biosciences?

IMU Biosciences is currently owned by IQ Capital Partners through IQ Capital Fund IV (2022 vintage), since 2024.

Hand-verified · updated 2026-07-08

IQ Capital Partners
Investor
IQ Capital Partners
IQ Capital Fund IV · 2022 · VC

Key facts

HQUK
SectorBiotech
StatusActive

More from IQ Capital Fund IV

Other portfolio companies in the same fund.

Isembard
Active
Aerospace & DefenceUK· 2026
Omegga
Active
HealthTechGermany· 2026
Alpine Eagle
Active
Aerospace & DefenceGermany· 2025
DaltonTx
Active
BiotechUK· 2025
RevEng.AI
Active
CybersecurityUnited States· 2025
Molyon
Active
Deep TechUK· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings